Reed's, INC

Reeds, Inc. announced the approval of its 2026 Equity Incentive Plan and the ratification of its independent auditor at its annual stockholder meeting.

Reeds, Inc. announced first quarter 2026 financial results, showing a significant decrease in net sales and gross profit, alongside an increased net loss, attributed to inventory rationalization and higher costs.

Reeds, Inc. has appointed former executive Damian Warshall as Chief Operating Officer to lead operational scaling and supply chain efficiency.

Reeds, Inc. has formalized the separation agreement with former CEO Cyril A. Wallace, Jr., detailing severance and equity compensation.

Reeds, Inc. announced its 2026 Annual Meeting of Stockholders will be held on June 10, 2026, with deadlines for stockholder proposals and nominations set for April 18, 2026.

Reeds, Inc. announced the resignation of CEO Cyril A. Wallace, Jr., effective March 24, 2026, with COO Neal M. Cohane appointed as interim CEO and director.

Reeds, Inc. reported a 4% increase in net sales for Q3 2025, but a 33% wider net loss for the nine months ended September 30, 2025, driven by higher operating expenses and inventory write-offs.

Reeds Inc. reported a significantly wider net loss and decreased gross profit in the first half of 2025, driven by strategic product portfolio changes and increased operating expenses, while securing $3 million in new capital.

Reeds, Inc. announces a 5% increase in net sales for Q1 2025, but continues to face net losses and is actively seeking refinancing for its senior secured loan.

Reeds Inc. reported a net loss of $9.035 million for the nine months ended September 30, 2024, alongside a decrease in net sales and ongoing concerns about its ability to continue as a going concern.

Reeds Inc. reports its Q2 2024 results, highlighting a complex financial landscape with increased revenue but ongoing losses, alongside securing additional funding and amending debt agreements.

Reeds Inc. saw a significant improvement in gross margin in the first quarter of 2024, despite a decrease in net sales compared to the same period last year.

Reeds Inc. reported a significant increase in net loss for fiscal year 2025, driven by declining sales and higher operating expenses, despite strategic investments in Asia-Pacific expansion and recent capital raises.

Reeds, Inc. announces its fiscal year 2024 results, highlighting debt restructuring efforts, a change in control, and a strategic focus on the functional beverage market with a new product line slated for April 2025.

Reeds Inc. has entered into a Simple Agreement for Future Equity (SAFE) with D&D Source of Life Holding Ltd., securing a $3 million investment.

Era Regenerative Medicine Ltd., a significant shareholder and director, has increased its beneficial ownership in REED'S, INC. by acquiring over 1 million shares through a private investment in public equity (PIPE) transaction.

Shufen Deng, a director of Reed's, Inc., transferred ownership of shares held through D&D Source of Life Holding Ltd. to an unaffiliated third party, relinquishing control over those shares.

Shufen Deng, a director and 10% owner of Reed's Inc., acquired 22.4 million shares through a debt-for-equity swap.

Union Square Park Capital Management, along with related entities, sold a portion of their Reed's Inc. common stock holdings in two transactions.

Director John Bello acquired 200,000 shares of Reed's, Inc. common stock through the conversion of a SAFE investment.

Union Square Park Capital Management, LLC and related entities report acquiring 531,205 shares of Reed's, Inc. common stock through the conversion of a SAFE investment.

Reeds, Inc. has issued a proxy statement announcing its 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, to elect directors, ratify auditors, and approve a new equity incentive plan.

REEDs, Inc. announces Board and majority stockholder approval for a discretionary reverse stock split, aiming to meet national exchange listing requirements and enhance marketability.

Reeds, Inc. discloses stockholder approval via written consent for director elections, auditor ratification, bylaw amendments, and a reduction in authorized common stock.

Reeds Inc. has filed an amendment to its S-1 registration statement, outlining the Warrant Agent Agreement with Transfer Online, Inc. for its upcoming public offering of common stock and warrants.

Reeds Inc. is offering 1.58 million shares of common stock and accompanying warrants to fund growth initiatives and working capital, following a 1-for-6 reverse stock split.

Reeds, Inc., a branded beverage company, is offering 1.33 million shares of common stock to fund growth initiatives and working capital, while also seeking a listing on the NYSE American.

Reeds, Inc. filed an S-1/A registration statement to allow certain accredited investors to resell up to 5 million shares of common stock, with the company receiving no proceeds from these sales.

Reeds, Inc. filed an S-1 registration statement to allow certain selling shareholders to resell up to 5,000,000 shares of common stock, with the company receiving no proceeds from these sales.

Reeds, Inc. filed an S-1 registration statement to allow certain selling shareholders, including its majority stockholder, to resell up to 3,225,807 shares of common stock, with the company receiving no proceeds from the sale.

A majority shareholder group led by D&D Source of Life Holding Ltd has encumbered nearly its entire 53.5% stake in Reed's, Inc. as collateral for third-party debt.

Era Regenerative Medicine Ltd and D&D Source of Life Holding Ltd have solidified their control over Reed's, Inc., now beneficially owning 57.8% of the common stock following recent share acquisitions and a corporate restructuring.

Era Regenerative Medicine Ltd has become the new holding company for D&D Source of Life Holding Ltd's 59.5% beneficial ownership stake in REED'S, INC. common stock, following a restructuring on December 31, 2024.

Era Regenerative Medicine Ltd has become the holding company for D&D Source of Life Holding Ltd, consolidating a 59.5% beneficial ownership stake in Reed's, Inc. following a series of strategic investments totaling over $23 million.

Reed's Inc. has announced significant changes in its major shareholder structure, with D&D Source of Life Holding Ltd. maintaining a controlling stake under new ownership and updated governance agreements.

Whitebox Advisors LLC, Whitebox General Partner LLC, and Whitebox Multi-Strategy Partners, LP have filed an amended Schedule 13G, reporting passive beneficial ownership of REED'S, INC. common stock as of December 31, 2024.